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Background/objective: Postoperative pancreatic fistula remains a major complication after
pancreatic surgeries. To prevent pancreatic fistula, one of the employed management
strategies is pancreatic duct stenting. The purpose of this study was to evaluate the efficacy
and safety of preoperative pancreatic stenting to prevent pancreatic fistula after surgery.
Methods: Subjects comprised 18 consecutive patients who underwent pancreatic surgeries.
Patients were divided into 2 groups: stenting group (n¼ 7); and non-stenting group (n¼ 11).
Complications after stent placement were analyzed. Compared parameters between
groups included background, incidence and grading of pancreatic fistula as judged by inter-
national study group of pancreatic fistula (ISGPF) criteria, duration until drain removal, and
mean maximum level of drain amylase.
Results: Two patients displayed mild pancreatitis with high serum amylase levels after
stenting. No significant differences in background or any other compared parameters to as-
sess drainage effect were identified between stenting and non-stenting groups. Complica-
tions related to placement of the stent tube occurred in 4 patients with tube occlusion or
cholestasis.
Conclusions: Although drainage effect in the stenting group was compared with that in the
non-stenting group, no obvious effect was obtained. This procedure seems to require fur-
ther investigation on indications for postoperative drainage to decrease the incidence of
pancreatic fistula.
ª 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction To prevent pancreatic fistula, one of the employed man-Postoperative pancreatic fistula remains amajor complication
after pancreatic surgeries.1–3 Not only conventional opera-
tions such as distal pancreatectomy, but also limited opera-
tions that have recently been advocated for patients with
neoplasms categorized as benign or low-grade malignancy
are highly associated with intraoperative injury of the pancre-
atic duct, which frequently results in pancreatic fistula.4–71x3251; fax: þ81 3 3480 8
amoto).
al Associates Ltd. Publishagement strategies is pancreatic duct stenting. Advances
in endoscopic techniques and safety management have
facilitated the placement of pancreatic stents.8–10 Several
reports have described perioperative pancreatic stenting
for the treatment of pancreatic fistula after surgery.11–17
Preoperative pancreatic stenting for prophylactic purposes
has thus been introduced to pancreatic surgery in our
institute.295.
ed by Elsevier Ltd. All rights reserved.
Table 1 – Comparison of background factors between
stenting and non-stenting groups
Stenting group
(n¼ 7)
Non-stenting
group (n¼ 11)
P
Gender (M:F) 5:2 6:5 0.5784
a a
i n t e rn a t i o n a l j o u rn a l o f s u r g e r y 6 ( 2 0 0 8 ) 2 1 0 – 2 1 3 211Some reports have noted complications after pancreatic
stenting are not uncommon and further studies are needed.18–20
Pancreatic stenting to prevent pancreatic fistula thus remains
controversial. The present study reviewed the cases of 18
patients to evaluate efficacy and safety of preoperative pan-
creatic stenting for the prevention of pancreatic fistula.
Age (years) 35–79 (63.6) 38–75 (58.2) 0.4369
Texture of the
pancreas (soft/hard)
3/4 6/5 0.6287
Dilatation of the main
pancreatic duct (þ/)
4/3 5/6 0.6287
Disease
Chronic pancreatitis 2 3 0.9522
Neoplasm 5 8
Operation 0.1542
PJb 2 2
Distal resection 2 8
Segmental resection 1 1
Partial resection 2 0
a Mean.
b Pancreatojejunostomy.2. Patients and methods
Subjects comprised 18 consecutive patients (11 men, 7
women) who underwent pancreatic surgeries other than pan-
creaticoduodenectomy between 2001 and 2007. Patients were
divided into 2 groups due to informed consent: the stenting
group, in which patients underwent preoperative pancreatic
stenting after obtaining informed consent (n¼ 7); and the
non-stenting group, in which patients refused preoperative
pancreatic stenting (n¼ 11). Pancreatic stents (diameter, 5 or
7 Fr; length, 9 or 12 cm; Cook, Bloomington, Indiana) were
placed in all patients through the papilla of Vater within 7
days before elective surgery.
Complications after stent placement in the stenting group
were analyzed. Parameters compared between groups in-
cluded background (gender, age, pancreas stiffness, incidence
of main pancreatic duct dilatation, diseases and operative
procedures), incidence of pancreatic fistula as judged accord-
ing to international study group of pancreatic fistula (ISGPF)
criteria, grading of pancreatic fistula according to ISGPF crite-
ria,21 duration from operation to drain removal, and mean
maximum level of drain amylase.
For statistical analysis, either Student’s t-test or the c2 test
was used to detect differences in parameters between groups.Table 2 – Comparison of parameters between stenting
and non-stenting groups
Stenting group
(n¼ 7)
Non-stenting
group (n¼ 11)
P
Incidence of pancreatic
leak by ISGPF
definition
3 (42.9%) 3 (27.3%) 0.9522
Grading by ISGPF 1/2/0 1/2/0 0.70943. Results
All patients in stenting group successfully underwent pancre-
atic stenting through the papilla of Vater. Two patients dis-
played mild pancreatitis with high serum amylase levels
after stenting. However, the surgical schedulewas not delayed
by these complications in either patient.
No significant differences in gender, age, pancreas stiff-
ness, incidence of main pancreatic duct dilatation, diseases
or operative procedures were identified between stenting
and non-stenting groups (Table 1).
Incidence of pancreatic fistula by ISGPF criteria, grading of
pancreatic fistula by ISGPF definition, duration from operation
to drain removal, and mean maximum level of drain amylase
likewise did not differ significantly between groups (Table 2).
Complications related to placement of the stent tube after
surgeries occurred in 4 patients. Tube occlusion requiring
stent exchange occurred in 2 patients. In addition, cholestasis
occurred in another 2 patients after tube removal and needed
biliary drainage.
definition (A/B/C)
Operation to drain
removal (days)
6–31 (16.8)a 3–30 (11.5)a 0.3869
Mean maximum
drain amylase
11,114 12,815 0.8743
a Mean.4. Discussion
With advances in endoscopic technology, indications for
pancreatic duct stenting have been expanded to variouspancreatic diseases.8–10 Several reports have indicated the ef-
fectiveness of postoperative pancreatic stenting for the treat-
ment of pancreatic fistula after surgery.11–14 A couple of
descriptions as to preoperative endoscopic treatment for
prophylaxis were also found.15–17 Abe et al. advocated pre-
operative endoscopic pancreatic stenting as an effective
prophylactic measure against pancreatic fistula after distal
pancreatectomy, and reported that none of their patients
with preoperative stenting developed pancreatic fistula.15 Hir-
ota et al. described that no patients who underwent preoper-
ative stenting indicated pancreatic fistula with grade C after
local resections.16 However, no comparison to a control group
was described in both of them.
In the present study, drainage effect was assessed by com-
paring stenting and non-stenting groups. However, no signif-
icant differences were noted between groups. One reason for
the different outcomesmay have been the number of patients
with distal pancreatectomy. Only 2 of 7 patients underwent
distal pancreatectomy in our series, contrasting with all 9
i n t e r n a t i o n a l j o u r n a l o f s u r g e r y 6 ( 2 0 0 8 ) 2 1 0 – 2 1 3212patients in the report by Abe et al.15 Pancreatic stenting after
distal pancreatectomy is likely to be effective for drainage,
as no pancreatic leakage was seen in those 2 patients in our
series. Another reason might be size of the stent. Although
Abe et al. used 7 Fr stents in all patients, 5 Fr stents were
used in 7 of 8 patients in our study.15 Larger-caliber stents
might contribute to more effective drainage, as pancreatic
leakage due to tube occlusion after surgery disappeared on
stent exchange to larger-caliber stents in 2 patients.
Regarding cholestasis several days after tube removal in
2 patients in our study, the mechanism seems to involve
edema of the papilla of Vater after tube removal. Since such
complications are unacceptable, further investigations are
warranted.
As standard definitions and grading for pancreatic fistula
have yet to be defined, outcomes in terms of complications af-
ter pancreatic surgeries cannot be exactly compared. How-
ever, Bassi et al. described ISGPF definitions and grading of
pancreatic fistula, which seem very useful and universal to
compare outcomes. Pancreatic fistula in our series was judged
according to their definitions.21 Our data will be able to be
compared to patients undergoing the same treatment in other
institutions.
Conversely, pancreatic duct stenting prior to pancreatic
surgery has been employed for the purpose of providing an
intraoperative guide to the feasibility of limited pancreatic re-
section and to preventmain pancreatic duct injury. Pancreatic
duct stenting prior to pancreatic surgery for such purposes
seems useful as another reports described.16,17,22–24
In conclusion, although pancreatic duct stenting prior to
pancreatic surgery was performed to prevent pancreatic fis-
tula and the drainage effect in the stenting group was com-
pared with that in a non-stenting group, no obvious effect
was identified.
This procedure warrants further investigation with regard
to indications for postoperative drainage to decrease the inci-
dence of pancreatic fistula.
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